News and Updates

How a few Breakthrough T1D families have been managing the challenges of working from home while home schooling during the pandemic, and their messages of hope for the T1D community.

Mark Poznansky, M.D., Ph.D., wants the seemingly impossible—a person with type 1 diabetes (T1D) has a procedure where beta cells are placed in their body, the doctor stitches it up and the person has functioning insulin-producing beta cells, for life. Of course, we’re not there yet, but, with Dr. Poznansky—and many, many other researchers—Breakthrough T1D […]

How to access the latest diabetes management tools through the Department of Veterans Affairs with Armed For Diabetes .

In this time of great uncertainty, there is some exciting news out of Europe. Innodia, a partnership between public and private entities working together to fund research aimed at biomarker discovery and the prevention of type 1 diabetes (T1D), received an additional €12 million in funding from the European Commission, Breakthrough T1D and the Helmsley […]

Credit: Diabetes Care In December 2017, the type 1 diabetes (T1D) community got a jolt, when a publication, testing the insulin concentrations in 18 vials, said that “none of the vials met the minimum labeled concentration standard.” In other words, insulin was not at the recommended dose; in fact, the percentage of insulin was around […]

Wouldn’t it be nice if you could take a vaccine in infancy, and type 1 diabetes would not develop? Preclinical research suggests it might not be that far away.

Carla Greenbaum, M.D., chair of TrialNet—an international Breakthrough T1D-supported network that is dedicated to finding cures for type 1 diabetes (T1D)—and a professor at Benaroya Research Institute, discussed T1D research in the time of COVID-19, including what TrialNet is up to, on Breakthrough T1D’s Facebook Live event. She chats about: What do we know now […]

Included: navigating the fundraising challenges brought by COVID-19, how Breakthrough T1D has evolved as an organization, life with T1D in the 1970s and 1980s, the crucial role of advocacy, and the importance of the T1D community working together.

It’s 2004. The California Institute for Regenerative Medicine (CIRM), which will fund $3 billion in stem cell research to advances new therapies, is on the ballot, if it gets approved. Fortunately, the patients, families and scientists were the voices that day, with nearly 60% voting to approve it. In the time since 2004, it has […]

Fifty years ago, two mothers came together to make the world a better place for their children and for other people burdened with type 1 diabetes.